Hancom Inc (030520)
KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 16,720.00 |
|---|---|
| 52-week range | 14,800.00 – 26,750.00 |
| Return, 1 month / 3 months | −3.9% / +1.8% |
| Return, 1 year / 3 years | −33.5% / +26.9% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 47.1% |
| Worst drawdown (1 year) | -42.9% |
| Average daily value traded | 2,184.28M KRW |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hancom Inc is a South Korean software company that develops office productivity programs. Its main offering is a suite of applications for word processing, spreadsheets and presentations, along with tools for viewing and editing documents and for working with files in common formats. The company also provides cloud-based collaboration and document services. Its customers include individual users, businesses and public institutions, mainly in Korea, and it is based in the Seoul metropolitan area.
On this site Hancom Inc appears as a stock on the KOSDAQ (Korea), code 030520, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hancom Inc (030520) trades on the KOSDAQ in Korea. It last closed at KRW 16,720.00 on 19 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 556 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 33.5% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -15.3% | ||
| From 52-week high | -37.0% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | -17.2% | ||
| 12-month return, skipping the last month | -30.9% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 47.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.9% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 2,184.28M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −3.9% |
| 3 months | +1.8% |
| 6 months | −17.2% |
| 1 year | −33.5% |
| 3 years | +26.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 17,508.40 / 19,750.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 768.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 400.0000 |
| 27 Dec 2024 | KRW 410.0000 |
| 27 Dec 2023 | KRW 410.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.